You are here

Global

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59

Tue, 2024-04-09 09:32 — mike kraft

Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use

A vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk of getting severely sick from respiratory syncytial virus in a late stage clinical trial, the company said Tuesday.

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer’s RSV vaccine shows potential to protect high-risk adults ages 18-59
Log in or register to post comments

Climate-warming refrigerant gases are being smuggled into Europe-- investigation

Mon, 2024-04-08 17:53 — mike kraft

Climate-warming gases being smuggled into Europe, investigation says Large amounts of climate-warming refrigerant gases from China and Turkey are being smuggled illegally into Europe, undermining a global pact to phase them out, a report by the London-based Environmental Investigation Agency (EIA) said on Monday. David Stanway Reuters

...

Country / Region Tags:

General Topic Tags:

Social behavior

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Climate-warming refrigerant gases are being smuggled into Europe-- investigation
Log in or register to post comments

Long covid linked to blood issues; signs of ongoing inflammatory responses --preliminary British study

Mon, 2024-04-08 17:40 — mike kraft

Long covid linked to signs of ongoing inflammatory responses in blood People with long covid after a serious covid-19 infection have raised levels of many immune molecules in their blood. Better understanding how these molecules can vary could lead to more targeted treatments #author.fullName} New Scientist

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

FDA Authorizes COVID Drug Pemgarda for High-Risk Patients

Mon, 2024-04-08 11:21 — mike kraft

FDA Authorizes COVID Drug Pemgarda for High-Risk Patients A Yale Medicine expert explains the significance of a new preventive medication to protect certain immunocompromised people against COVID-19. Yale Medicine

The Food and Drug Administration (FDA) granted an emergency use authorization (EUA) to a medicine meant to protect certain immunocompromised people against COVID-19.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA Authorizes COVID Drug Pemgarda for High-Risk Patients
Log in or register to post comments

Vigorous exercise may be OK for people with long COVID-new Swedish study

Mon, 2024-04-08 10:11 — mike kraft

No need to avoid exercise with long-COVID diagnosis, researchers say Recommendations that people with long COVID, or post-COVID condition (PCC), should avoid vigorous exercise are probably too strict, according to a new study published in JAMA Network Open from researchers at the Karolinska Institutet in Sweden. CIDRAP

Country / Region Tags:

General Topic Tags:

Social behavior

Problem, Solution, SitRep, or ?:

Read more about Vigorous exercise may be OK for people with long COVID-new Swedish study
Log in or register to post comments

Analysis: How climate change is increasing immune health problems and how to counter it

Fri, 2024-04-05 10:36 — mike kraft

How climate change is driving a global epidemic of immune health problems, and how to stop it Every $1 spent on mitigating climate change would save at least $3 in health care costs, largely through a reduction of diseases such as asthma and allergies. Patrick Skerrett STAT

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Read more about Analysis: How climate change is increasing immune health problems and how to counter it
Log in or register to post comments

Paxlovid does not shorten COVID symptoms among fully vaccinated--study

Fri, 2024-04-05 10:21 — mike kraft

Among fully vaccinated, study shows Paxlovid does not shorten symptoms A new study in the New England Journal of Medicine suggests that, for those fully vaccinated against COVID-19 but having at least one risk factor for severe COVID, the antiviral drug Paxlovid did little to reduce symptom duration, but experts caution the findings might not apply to older patients. CIDRAP

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Paxlovid does not shorten COVID symptoms among fully vaccinated--study
Log in or register to post comments

Bird flu: Contrasting views on potential danger to humans

Fri, 2024-04-05 10:10 — mike kraft

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Bird flu: Contrasting views on potential danger to humans
Log in or register to post comments

WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses

Thu, 2024-04-04 17:22 — mike kraft

WHO Launches 'CoViNet' To Track Evolution And Spread Of High-Threat Coronaviruses - Health Policy Watch The World Health Organization (WHO) has launched a new network, CoViNet, aimed at identifying, monitoring, and evaluating SARS-CoV-2, MERS-CoV, and emerging Health Policy Watch

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO Launches ‘CoViNet’ to Track Evolution and Spread of High-Threat Coronaviruses
Log in or register to post comments

Overall global life expectancy increased as world addressed major killers, though Covid pandemic had impact

Thu, 2024-04-04 12:19 — mike kraft

Covid cut life expectancy by 1.6 years globally, but the leading causes of death haven’t changed since 1990 The top causes of death globally — heart disease, stroke, COPD, and lower respiratory infections — were unchanged since 1990 except for two years of Covid pandemic. Annalisa Merelli STAT

...

Country / Region Tags:

General Topic Tags:

Public Attitudes

Problem, Solution, SitRep, or ?:

Pages